Kondo T, Ezzat S, Sylvia LA. (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nature Reviews Cancer. 6:292–306.

CAS  Article  Google Scholar 

Moo-Young TA, Traugott AL, Moley JF. (2009) Sporadic and familial medullary thyroid carcinoma: state of the art. Surg Clin North Am. 89:1193–1204.

Article  Google Scholar 

Kakudo K, Carney JA, Sizemore GW. Medullary carcinoma of thyroid. Biologic behavior of the sporadic and familial neoplasm. Cancer. 1985;55:2818–2821.

O’Riordain DS, O’Brien T, Weaver AL, et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery. 1994;116:1017–1023.

PubMed  Google Scholar 

Zedenius J, Larsson C, Bergholm U, et al. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab. 1995;80:3088–3090.

CAS  PubMed  Google Scholar 

Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, et al. (2014) Predictive factors that influence the course of medullary thyroid carcinoma. Int J Clin Oncol. 19:445–451.

Article  Google Scholar 

Qu N, Shi R-L, Luo T-X, et al. (2016) Prognostic significance and optimal cutoff of age in medullary thyroid cancer. Oncotarget. 7:15937–15947.

Article  Google Scholar 

Xu B, Fuchs TL, Ahmadi S, et al. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022;40:96–104.

Article  Google Scholar 

Wells SAJ, Asa SL, Dralle H, et al. (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25:567–610.

Article  Google Scholar 

Rajeev P, J. SH, N. ME, et al. (2017) Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Ann R Coll Surg Engl. 99:151–154.

Article  Google Scholar 

Mathiesen JS, Kroustrup JP, Vestergaard P, et al. (2019) Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect. 8:1–7.

Article  Google Scholar 

Adam MA, Thomas S, Roman SA, et al. (2017) Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer. JAMA Surg. 152:869–876.

Article  Google Scholar 

Tang J, Jiang S, Gao L, et al. (2021) Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery. Ann Surg Oncol. 28:4360–4370.

Article  Google Scholar 

Shaha AR. Extrathyroidal extension-what does it mean. Oral Oncol. 2017;68:50–52.

Article  Google Scholar 

Liu Z, Huang Y, Chen S, et al. (2019) Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system? PLoS One. 2019;14:e0218171.

CAS  Article  Google Scholar 

Frederick L. Greene, Stephen E, Schilsky RL, et al. Part XVII. Endocrine System (2017). In: Amin MB, Edge S, Greene F, et al., editors. In: AJCC Cancer Staging Manual. 8th ed. New York: Springer; p. 891–899.

Google Scholar 

Frank E.Harrel J. Chapter 4. Multivariable Modeling Strategies. Regression Modeling Strategies With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. Second. New York: Springer International Publishing; 2015. p. 92–94.

Efron B, Gong G. (1983) A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation. The American Statistician. 37:36–48.

Google Scholar 

Scheuba C, Kaserer K, Kaczirek K, et al. Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative “marker” for lymph node metastases. World J Surg. 2006;30:853–859.

Article  Google Scholar 

Koperek O, Scheuba C, Puri C, et al. Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol. 2007;31:59–67.

CAS  PubMed  Google Scholar 

Machens A, Dralle H. (2010) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 95:2655–2663.

CAS  Article  Google Scholar 

Kim M, Kim BH. (2021) Current Guidelines for Management of Medullary Thyroid Carcinoma. Endocrinol Metab (Seoul). 36:514–524.

CAS  Article  Google Scholar 

Chen L, Wang Y, Zhao K, et al. (2020) Postoperative Nomogram for Predicting Cancer-Specific and Overall Survival among Patients with Medullary Thyroid Cancer. Int J Endocrinol. 2020:8888677.

PubMed  PubMed Central  Google Scholar 

Rahbari R, Zhang L, Kebebew E. (2010) Thyroid cancer gender disparity. Future Oncol. 6:1771.

CAS  Article  Google Scholar 

Kotwal A, Erickson D, Geske JR, et al. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades. Thyroid. 2021;31:616–626.

CAS  Article  Google Scholar 

Sahli ZT, Canner JK, Zeiger MA, et al. (2021) Association between age and disease specific mortality in medullary thyroid cancer. Am J Surg. 221:478–484.

Article  Google Scholar 

Zhao Z, Yin X-D, Zhang X-H, et al. (2020) Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program. Sci Rep. 10:13310.

CAS  Article  Google Scholar 

Fan W, Xiao C, Wu F. (2018) Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma. J Int Med Res. 46:1982–1989.

Article  Google Scholar